1. 2022-RA-1392-ESGO Tisotumab vedotin combinations with pembrolizumab or carboplatin in patients with recurrent/metastatic cervical cancer: interim results of ENGOT Cx8/GOG-3024/innovaTV205. (20th October 2022) Authors: Lorusso, Domenica; Vergote, Ignace; O'Cearbhaill, Roisin E; Westermann, Anne M; Banerjee, Susana; van Nieuwenhuysen, Els; Iglesias, David A; Collins, Dearbhaile; Cibula, David; Madsen, Kristine; Tewari, Krishnansu S; Pignata, Sandro; Baurain, Jean-Francois; Boere, Ingrid A; Denys, Hannelore; Andr... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A57 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Endometrial Cancer Characteristics and Risk of Recurrence: The Role of Epigenetic Silencing of MLH1. Issue 1 (31st August 2021) Authors: Borden, Lindsay E; Locklear, Tonja M; Grider, Douglas J; Osborne, Janet L; Saks, Erin J; Valea, Fidel A; Iglesias, David A Journal: American journal of clinical pathology Issue: Volume 157:Issue 1(2022) Page Start: 90 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗